Harnessing systems biology by integrating proteomics and immunopeptidomics to understand prostate cancer carcinogenesis, diagnosis and treatment

点击翻译按钮获取中文摘要

This ECF proposal aims to systematic profile to proteomic compositions of prostate normal, and cancer cells, and utilise such data to develop innovative systems biology models that will enable accurate prediction of tumour associate antigen (TAA) presentation for both aggressive and nonaggressive prostate cancer. The outcomes of this project will generate urgently needed knowledge for understanding TAA presentation and contribute to identification of tractable targets for vaccine development.